PuraPharm (HKSE:01498) Total Stockholders Equity : HK$153.2 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is PuraPharm Total Stockholders Equity?

PuraPharm's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$153.2 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. PuraPharm's Book Value per Share for the quarter that ended in Dec. 2023 was HK$0.39. The ratio of a company's debt over equity can be used to measure how leveraged this company is. PuraPharm's Debt-to-Equity for the quarter that ended in Dec. 2023 was 2.77.

PuraPharm Total Stockholders Equity Historical Data

The historical data trend for PuraPharm's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuraPharm Total Stockholders Equity Chart

PuraPharm Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

362.12

511.66

401.56

258.29

153.24

PuraPharm Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															401.56	354.02	258.29	216.33	153.24

PuraPharm (HKSE:01498) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

PuraPharm's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(153.236	-	0)	/	395.897
	=	0.39

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

PuraPharm's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(321.995	+	102.775)	/	153.236
	=	2.77

PuraPharm Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PuraPharm's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PuraPharm (HKSE:01498) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PuraPharm Corporation Ltd (HKSE:01498) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

Wireless Centre, Phase One, Unit 201-207, 2nd Floor, Hong Kong Science Park, Tai Po, New Territories, Hong Kong, HKG

Website

https://www.purapharm.com

PuraPharm Corporation Ltd is a Hong Kong-based Chinese medicine Company. It is engaged in the research and development, production, marketing and sale of concentrated Chinese medicine granules (CCMG) products marketed under the brand Nong's. In addition, the organization is engaged in rendering Chinese medical diagnostic services. The operating segments of the group are China CCMG, Hong Kong CCMG, Chinese healthcare products, Plantation and Clinics. It generates maximum revenue from the China CCMG segment mainly engages in the production and sale of CCMG products in China. The group derives revenue from the customers located in Hong Kong, Mainland China and Other countries.

PuraPharm (HKSE:01498) Headlines

No Headlines